Novo Nordisk Adr (NVO)

Jul 15, 2026

NVO Stock Quote Price and Forecast - CNN

Jul 15, 2026

Jul 15, 2026

Oral Obesity Therapies Market to Reach $6.32 Billion by 2030 as Demand for GLP-1 Treatments Accelerates - GlobeNewswire Inc.

Jul 15, 2026

Jul 14, 2026

NVOH ETF Profile: Dividends, Returns (AMEX:NVOH) - TradingView

Jul 14, 2026

Jul 13, 2026

Novo Nordisk A/Sshare repurchase programme - Finansavisen

Jul 13, 2026

Jul 12, 2026

Novo Nordisk (NVO) Stock May Be 50% Undervalued Despite Medicare GLP 1 Coverage - Sahm

Jul 12, 2026

Jul 08, 2026

Novo Nordisk (NYSE:NVO) Updates Wegovy Label In Singapore With 21% Weight Loss Data - Sahm

Jul 08, 2026

Jul 06, 2026

Total equity of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVOD - TradingView

Jul 06, 2026

Jul 06, 2026

Weekly Recap: NOVO_B MAR buyback and Shares jump after UK Wegovy approval - TradingView

Jul 06, 2026

Jul 04, 2026

Novo Nordisk (NVO) Wins UK Wegovy Pill Approval As Medicare Opens GLP 1 Access - Sahm

Jul 04, 2026

Jul 02, 2026

NVONovo Nordisk ADR Options - Finviz

Jul 02, 2026

Jul 02, 2026

Market news - investments.halifax.co.uk

Jul 02, 2026

Jul 01, 2026

European ADRs Slid In US Trading On Wednesday - Finimize

Jul 01, 2026

Jun 29, 2026

Novo Nordisk holds analyst rating, JPMorgan reiterates Neutral on the shares - Ad Hoc News

Jun 29, 2026

Jun 29, 2026

Novo Nordisk consensus picture, shares backed by strong obesity demand - Ad Hoc News

Jun 29, 2026

Jun 26, 2026

NOVA Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 26, 2026

NVO Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 26, 2026

Novo Nordisk consensus shifts after analyst moves, shares trade lower in Europe - AD HOC NEWS

Jun 26, 2026

Jun 25, 2026

Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B - TradingView

Jun 25, 2026

Jun 25, 2026

Novo Nordisk consensus after Morningstar downgrade, shares remain in focus on NYSE and Copenhagen - Ad Hoc News

Jun 25, 2026

Jun 25, 2026

NVO/N Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 25, 2026

Non-controlling/minority interest of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVOC - TradingView

Jun 25, 2026

Jun 24, 2026

Novo Nordisk (NYSE: NVO) repurchases 20,959,179 shares in 2026 - Stock Titan

Jun 24, 2026

Jun 23, 2026

Novo Nordisk updates analyst targets, shares stay in S&P 500 focus - AD HOC NEWS

Jun 23, 2026

Jun 23, 2026

Novo Nordisk Stock Is Surging Monday: What's Driving The Action? - Sahm

Jun 23, 2026

Jun 23, 2026

Novo Nordisk wins key South Africa ruling, shares extend obesity-drug lead - Ad Hoc News

Jun 23, 2026

Jun 22, 2026

Wegovy from Novo Nordisk A/ S (ADR)weekly injection reshapes obesity care - AD HOC NEWS

Jun 22, 2026

Jun 22, 2026

European ADRs Open The Week Higher In US Trading - Finimize

Jun 22, 2026